Turn Therapeutics Inc. (TTRX)
Turn Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Turn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec '24 Dec '23
Debt / Equity Ratio
0.06-0.680.29
Debt / EBITDA Ratio
-0.04-0.07-0.01
Debt / FCF Ratio
-0.06-0.08-0.02
Quick Ratio
3.011.232.41
Return on Equity (ROE)
-144.18%996.67%-2672.64%
Return on Assets (ROA)
--86.31%-113.84%
Return on Capital (ROIC)
-146.78%3186.62%-2080.84%
Return on Capital Employed (ROCE)
243.34%-134.02%-151.48%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).